Ads
related to: bristol-myers squibbcatalent.com has been visited by 10K+ users in the past month
Search results
7 Underappreciated Stocks With 25% Return Potential in 2024
InvestorPlace· 6 days agoWhether investors refer to them as undervalued or hidden gems, underappreciated stocks are always...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 3 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Novartis leukemia drug more effective than older treatments in trial
AOL· 5 days agoSwiss drugmaker Novartis said patients with a type of leukemia who took its Scemblix had a significantly better response and a lower dropout rate than those who received current standard-of-care ...
ASCO 2024: Precede Biosciences assay classifies HER2 and ER status in cancers
Clinical Trials Arena via Yahoo Finance· 2 days agoPrecede Biosciences has announced positive results for its novel liquid biopsy assay, which can...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 4 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed...
Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma
MedPage Today· 1 day agoCombination neoadjuvant immunotherapy for resectable melanoma reduced recurrence and other clinical...
1st-Quarter Earnings Season Results, Expectations for 2024
Guru Focus· 7 days agoFirst-quarter earnings season has become one of the important market supporting factors during...
Dividends Are a Benefit, But Only From Companies That Can Afford to Pay Them | Investing.com
Investing.com· 24 hours agoFew financial topics have been the subject of more articles than dividend investing, and for good...
GSK blood cancer drug nearly halves risk of death in late-stage trial
AOL· 3 days agoGSK's multiple myeloma drug Blenrep nearly halved the risk of disease progression or death compared to standard-of-care treatments for the incurable blood cancer, according to data from a late-stage ...
GSK builds case for return of multiple myeloma drug Blenrep
BioPharma Dive via Yahoo Finance· 3 days agoStudy results showed the antibody-drug conjugate helped stave off disease progression better than a...